Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Intangibles (2016 - 2025)

Neuroone Medical Technologies' Intangibles history spans 8 years, with the latest figure at $39368.0 for Q4 2025.

  • For Q4 2025, Intangibles fell 36.18% year-over-year to $39368.0; the TTM value through Dec 2025 reached $39368.0, down 36.18%, while the annual FY2025 figure was $44946.0, 33.18% down from the prior year.
  • Intangibles reached $39368.0 in Q4 2025 per NMTC's latest filing, down from $44946.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $145365.0 in Q1 2021 to a low of $39368.0 in Q4 2025.
  • Average Intangibles over 5 years is $92366.2, with a median of $92366.5 recorded in 2023.
  • Peak YoY movement for Intangibles: decreased 14.78% in 2021, then crashed 36.18% in 2025.
  • A 5-year view of Intangibles shows it stood at $128628.0 in 2021, then decreased by 17.35% to $106313.0 in 2022, then fell by 20.99% to $83998.0 in 2023, then fell by 26.57% to $61683.0 in 2024, then plummeted by 36.18% to $39368.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Intangibles are $39368.0 (Q4 2025), $44946.0 (Q3 2025), and $50525.0 (Q2 2025).